Cargando…
Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice
Brain insulin signaling deficits contribute to multiple pathological features of Alzheimer's disease (AD). Although intranasal insulin has shown efficacy in patients with AD, the underlying mechanisms remain largely unillustrated. Here, we demonstrate that intranasal insulin improves cognitive...
Autores principales: | Mao, Yan‐Fang, Guo, Zhangyu, Zheng, Tingting, Jiang, Yasi, Yan, Yaping, Yin, Xinzhen, Chen, Yanxing, Zhang, Baorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013027/ https://www.ncbi.nlm.nih.gov/pubmed/27457264 http://dx.doi.org/10.1111/acel.12498 |
Ejemplares similares
-
Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer’s rat model
por: Guo, Zhangyu, et al.
Publicado: (2017) -
Amyloid pathology induces dysfunction of systemic neurotransmission in aged APPswe/PS2 mice
por: Oh, Se Jong, et al.
Publicado: (2022) -
Corrigendum: Amyloid pathology induces dysfunction of systemic neurotransmission in aged APPswe/PS2 mice
por: Oh, Se Jong, et al.
Publicado: (2022) -
Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice
por: Chen, Yanxing, et al.
Publicado: (2021) -
Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease
por: Ahmed, Sara, et al.
Publicado: (2022)